Therapeutic delivery of mRNA: the medium is the message.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Development and protective evaluation of mRNA vaccines encoding the glycoprotein precursor of lymphocytic choriomeningitis virus.Virus research · 2026
   Article
2. Extracellular Vesicle-Based mRNA Therapeutics and Vaccines.Exploration (Beijing, China) · 2025
   Review
3. Inner leaflet cationic lipid increases nucleic acid loading independently of outer leaflet lipid charge in asymmetric liposomes.Methods (San Diego, Calif.) · 2023
   Article
4. Modified mRNA Therapeutics for Heart Diseases.International journal of molecular sciences · 2022
   Review
5. Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment.Archives of pharmacal research · 2022
   Review
6. Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects.Journal of nanobiotechnology · 2022
   Review
7. Speed Microscopy: High-Speed Single Molecule Tracking and Mapping of Nucleocytoplasmic Transport.Methods in molecular biology (Clifton, N.J.) · 2022
   Article
8. Microfluidic transfection of mRNA into human primary lymphocytes and hematopoietic stem and progenitor cells using ultra-fast physical deformations.Scientific reports · 2021
   Article
9. Recent advances in gene therapy for atrial fibrillation.Journal of cardiovascular electrophysiology · 2021
   Review
10. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope.BMC biotechnology · 2021
    Review
11. Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review).Experimental and therapeutic medicine · 2021
    Review
12. Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins.Science advances · 2020
    Article
13. Nuclear export of mRNA molecules studied by SPEED microscopy.Methods (San Diego, Calif.) · 2019
    Review
14. MTissue engineering. Part A · 2019
    Article
15. Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma.Journal for immunotherapy of cancer · 2018
    Article
16. Interfacially Engineered Pyridinium Pseudogemini Surfactants as Versatile and Efficient Supramolecular Delivery Systems for DNA, siRNA, and mRNA.ACS applied materials & interfaces · 2017
    Article
17. Optimizing Cardiac Delivery of Modified mRNA.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
18. Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
19. Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo.Nano letters · 2016
    Article
20. Three-Dimensional Mapping of mRNA Export through the Nuclear Pore Complex.Genes · 2014
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as